ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.460,25
0,19%
S&P 500
5.998,74
-0,38%
Dow Jones
44.722,06
-0,31%
Euro vs US Dollar
1,05588
-0,02%
Bitcoin
97.311,90
1,73%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Kanada
  5. TSX
  6. Crescita Therapeutics Inc (CTX)

  7. Crescita Therapeutics Inc (CTX) News

CTX

Crescita Therapeutics (CTX)

Crescita Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:TSX:CTX
DatumZeitQuelleÜberschriftSymbolFirma
01/06/202311h00PR Newswire (Canada)Croma-Pharma: Launch of topical anaesthetic Pliaglis® in EuropeTSX:CTXCrescita Therapeutics Inc
01/06/202311h00PR Newswire (US)Croma-Pharma: Launch of topical anaesthetic Pliaglis® in EuropeTSX:CTXCrescita Therapeutics Inc
01/06/202311h00PR Newswire (US)Croma-Pharma: Launch of topical anaesthetic Pliaglis® in EuropeTSX:CTXCrescita Therapeutics Inc
21/01/202113h30PR Newswire (US)Crescita Announces Filing of New Medical Device LicenseTSX:CTXCrescita Therapeutics Inc
21/01/202113h30PR Newswire (Canada)Crescita Announces Filing of New Medical Device LicenseTSX:CTXCrescita Therapeutics Inc
26/11/202013h30PR Newswire (Canada)Crescita Therapeutics Announces Approval of Normal Course Issuer BidTSX:CTXCrescita Therapeutics Inc
26/11/202013h30PR Newswire (US)Crescita Therapeutics Announces Approval of Normal Course Issuer BidTSX:CTXCrescita Therapeutics Inc
12/11/202013h30PR Newswire (Canada)Crescita Reports Third Quarter 2020 ResultsTSX:CTXCrescita Therapeutics Inc
12/11/202013h30PR Newswire (US)Crescita Reports Third Quarter 2020 ResultsTSX:CTXCrescita Therapeutics Inc
05/11/202013h30PR Newswire (Canada)Crescita Announces Licensing Agreement for Pliaglis® in ChinaTSX:CTXCrescita Therapeutics Inc
05/11/202013h30PR Newswire (US)Crescita Announces Licensing Agreement for Pliaglis® in ChinaTSX:CTXCrescita Therapeutics Inc
12/08/202013h30PR Newswire (US)Crescita Reports Second Quarter 2020 ResultsTSX:CTXCrescita Therapeutics Inc
12/08/202013h30PR Newswire (Canada)Crescita Reports Second Quarter 2020 ResultsTSX:CTXCrescita Therapeutics Inc
28/07/202013h30PR Newswire (US)Crescita to Receive One-time Cash Payment Following Amendment to Pliaglis® U.S. Licensing AgreementTSX:CTXCrescita Therapeutics Inc
28/07/202013h30PR Newswire (Canada)Crescita to Receive One-time Cash Payment Following Amendment to Pliaglis® U.S. Licensing AgreementTSX:CTXCrescita Therapeutics Inc
27/05/202013h30PR Newswire (US)Crescita Reports First Quarter 2020 ResultsTSX:CTXCrescita Therapeutics Inc
27/05/202013h30PR Newswire (Canada)Crescita Reports First Quarter 2020 ResultsTSX:CTXCrescita Therapeutics Inc
14/05/202014h30PR Newswire (US)Crescita Therapeutics Announces the Results of its Annual General Meeting of ShareholdersTSX:CTXCrescita Therapeutics Inc
14/05/202014h30PR Newswire (Canada)Crescita Therapeutics Announces the Results of its Annual General Meeting of ShareholdersTSX:CTXCrescita Therapeutics Inc
28/04/202023h58PR Newswire (US)Crescita Therapeutics Announces Extension of First Quarter 2020 Filings Due to COVID-19TSX:CTXCrescita Therapeutics Inc
28/04/202023h58PR Newswire (Canada)Crescita Therapeutics Announces Extension of First Quarter 2020 Filings Due to COVID-19TSX:CTXCrescita Therapeutics Inc
25/03/202000h23PR Newswire (US)Crescita Therapeutics Announces Measures in Response to COVID-19 VirusTSX:CTXCrescita Therapeutics Inc
25/03/202000h23PR Newswire (Canada)Crescita Therapeutics Announces Measures in Response to COVID-19 VirusTSX:CTXCrescita Therapeutics Inc
18/03/202012h30PR Newswire (US)Crescita Reports Q4 and Fiscal 2019 ResultsTSX:CTXCrescita Therapeutics Inc
18/03/202012h30PR Newswire (Canada)Crescita Reports Q4 and Fiscal 2019 ResultsTSX:CTXCrescita Therapeutics Inc
10/03/202014h30PR Newswire (Canada)Pliaglis® finally available in CanadaTSX:CTXCrescita Therapeutics Inc
10/03/202014h30PR Newswire (Canada)Pliaglis® enfin disponible au CanadaTSX:CTXCrescita Therapeutics Inc
11/02/202013h30PR Newswire (US)Crescita Announces Positive Topline Results from Two Pivotal Phase 3 Clinical Studies for its Lead Pipeline Product in Patien...TSX:CTXCrescita Therapeutics Inc
11/02/202013h30PR Newswire (Canada)Crescita Announces Positive Topline Results from Two Pivotal Phase 3 Clinical Studies for its Lead Pipeline Product in Patien...TSX:CTXCrescita Therapeutics Inc
24/01/202013h30PR Newswire (US)Crescita Awarded Cannabis Research License from Health CanadaTSX:CTXCrescita Therapeutics Inc
 Showing the most relevant articles for your search:TSX:CTX

Kürzlich von Ihnen besucht

BIT
SS7MIB
Societe Generale Effekten
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten

BLACK FRIDAY

ADVFN

Seit 25 Jahren im Geschäft 1999-2024

Sparen Sie bis zu 60%* für Euronext Level 2

1 Jahr 40%, 2 Jahre 50% und *3 Jahre 60%

*Über 3 Jahre 1094.04€, jetzt nur noch 437.62€